We are live on ! Find out more
Russell Investments Group

Russell Investments Group Portfolio holdings

AUM $114B
1-Year Est. Return 41.71%
This Fund
S&P 500
This Quarter Est. Return
+11.86%
1 Year Est. Return
+41.71%
3 Year Est. Return
+123.74%
5 Year Est. Return
+158.32%
10 Year Est. Return
AUM
$63.4B
AUM Growth
+$7.19B
Cap. Flow
+$2.26B
Cap. Flow %
3.57%
Top 10 Hldgs %
20.45%
Holding
3,416
New
220
Increased
1,562
Reduced
1,192
Closed
117

Top Buys

Rank Stock Value
1
BAC.PRL icon
Bank of America Series L
BAC.PRL
+$245M
2
MSFT icon
Microsoft
MSFT
+$173M
3
AMZN icon
Amazon
AMZN
+$155M
4
NVDA icon
NVIDIA
NVDA
+$133M
5
AAPL icon
Apple
AAPL
+$93.5M

Sector Composition

Rank Sector Weight
1 Technology 24.12%
2 Financials 12.98%
3 Healthcare 11.43%
4 Consumer Discretionary 10.44%
5 Real Estate 8.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GRTS
3126
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$447 ﹤0.01%
174
XERS icon
3127
Xeris Biopharma Holdings
XERS
$1.53B
$446 ﹤0.01%
+202
New +$523
ALKT icon
3128
Alkami Technology
ALKT
$2.12B
$442 ﹤0.01%
18
SPWR
3129
DELISTED
SunPower Corporation Common Stock
SPWR
$438 ﹤0.01%
+146
New +$481
CUTR
3130
DELISTED
Cutera, Inc.
CUTR
$435 ﹤0.01%
+296
New +$769
LBPH
3131
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
$432 ﹤0.01%
+20
New +$436
OMGA
3132
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
$423 ﹤0.01%
+116
New +$445
MAXN
3133
DELISTED
Maxeon Solar Technologies
MAXN
$420 ﹤0.01%
+1
New +$450
VRCA icon
3134
Verrica Pharmaceuticals
VRCA
$89.7M
$420 ﹤0.01%
7
ATOM icon
3135
Atomera
ATOM
$217M
$419 ﹤0.01%
+68
New +$466
OLMA icon
3136
Olema Pharmaceuticals
OLMA
$913M
$419 ﹤0.01%
+37
New +$477
IAUX
3137
i-80 Gold Corp
IAUX
$1.44B
$414 ﹤0.01%
309
JANX icon
3138
Janux Therapeutics
JANX
$1.01B
$414 ﹤0.01%
+11
New +$240
OBT icon
3139
Orange County Bancorp
OBT
$520M
$414 ﹤0.01%
+18
New +$428
EYPT icon
3140
EyePoint Inc
EYPT
$1.13B
$413 ﹤0.01%
+20
New +$495
NDLS icon
3141
Noodles & Co
NDLS
$93M
$411 ﹤0.01%
+27
New +$527
PMTS icon
3142
CPI Card Group
PMTS
$352M
$411 ﹤0.01%
23
-120
-84% -$2.19K
TSVT
3143
DELISTED
2seventy bio
TSVT
$407 ﹤0.01%
76
-17
-18% -$80
YMAB
3144
DELISTED
Y-mAbs Therapeutics
YMAB
$407 ﹤0.01%
25
-16,903
-100% -$228K
BKE icon
3145
Buckle
BKE
$2.37B
$403 ﹤0.01%
10
-4,753
-100% -$187K
NKTX icon
3146
Nkarta
NKTX
$167M
$400 ﹤0.01%
+37
New +$385
VYGR icon
3147
Voyager Therapeutics
VYGR
$197M
$400 ﹤0.01%
+43
New +$363
SENEA icon
3148
Seneca Foods Class A
SENEA
$1.25B
$398 ﹤0.01%
+7
New +$364
OPRX icon
3149
OptimizeRx
OPRX
$130M
$377 ﹤0.01%
31
BALY icon
3150
Bally's
BALY
$635M
$376 ﹤0.01%
27

Similar funds

Russell Investments Group's Q1 2024 Portfolio in Review

As of Q1 2024, Russell Investments Group held 3,416 positions worth $63.4B, up 13% from $56.2B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Russell Investments Group deployed $2.26B of net new capital in Q1 2024, opening 220 new positions and adding to 1,562 existing holdings. Its largest new stake was American Healthcare REIT: 1,381,759 shares worth $20.4M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was SLB Ltd, an estimated $96.9M trimmed.

  • Russell Investments Group's largest Q1 2024 buy was American Healthcare REIT: 1,381,759 shares worth $20.4M.
  • Russell Investments Group added most to Bank of America Series L in Q1 2024, an estimated $245M increase.
  • Russell Investments Group's biggest Q1 2024 reduction was SLB Ltd, cutting an estimated $96.9M.
  • Russell Investments Group fully exited SPIRIT REALTY CAPITAL, INC. in Q1 2024, selling an estimated $64.3M.
  • Russell Investments Group's ten largest holdings make up 20% of its $63.4B portfolio in Q1 2024.
  • Russell Investments Group opened 220 new positions and closed 117 in Q1 2024.
  • Russell Investments Group's portfolio value rose 13% quarter-over-quarter to $63.4B.

Based on Russell Investments Group's 13F filing for Q1 2024, filed 8 May 2024.